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BOTULISM
BoNTs block the release of acetylcholine attaching to the end of the
motor neurons in the neuromuscular junction, which does not allow the
interaction between this neurotransmitter and the muscle receptor,
preventing the nerve impulse from reaching the muscle, and the
muscle contraction cannot be produced
Davletov B, Bajohrs M, Binz T. Beyond BOTOX:
Advantages and limitations of individual botulinum
neurotoxins. 2005
Figure: Serotypes that produce food-
borne
Types of botulism
Food-borne botulism: ingestion of food
containing preformed BoNT (mainly home-
canned foods)
Infantil botulism: consuming the spores,
which then germinate in the intestines and
release the toxin in vivo
Wound botulism: organisms multiply and
produce toxin in a contaminated wound
Hidden botulism or Adult Intestinal
Colonization Botulism: no apparent source
of botulinum toxin found
Inadvertent or Iatrogenic botulism:
accidental occupational exposure or
complication in their therapeutically use
Inhalational (bioterrorism)
Symptoms: A characteristic acute,
symmetric, descending flaccid paralysis with
prominent bulbar palsies
And visual disturbances, dry mouth,
difficulty swallowing…
Mortality: In the past 50 years has fallen
from about 50% to 3-5%
Diagnosis: The standard confirmatory test
for botulism is a Mouse Bioassay 
presence of the neurotoxin in a food
sample, patient’s blood, gastric contents or
stool
Therapy: Passive immunization with H-
BAT antitoxin (against all 7 BoNT) or
BabyBIG-IV (for infants) + supportive care +
rehabilitation
Immunization: There is no routine
vaccination against botulism and
antitoxins are not useful for preventive
purposes
Vaccine under development:
Recombinant Botulinum Vaccine
(rBV A/B)
Prevention
Category A select agent (CDC)
Botulism is likely to occur as SPORADIC ATTACKS, due to 
the difficulties in dispersing the toxin
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Clostridium botulinum is a Gram-positive, rod-shaped bacterium that produces the most potent
substance known  the botulinum toxin (BoNT), responsible of the neuroparalytic illness called
botulism.
1µg is lethal to a person and only 1g of crystallized toxin is enough to kill a million people!!
C. botulinum can produce 7 different types of neurotoxin, distinguished by their antigenic
characteristics.
It is an obligate anaerobe with peritrichous flagella and oval subterminal spores.
This microorganism was first recognized and isolated in 1895 by Emile van Ermengem who described
the toxicological mechanisms of action responsible for botulism.
This organism and its spores are globally distributed in nature (both terrestrial and aquatic
ecosystems) but it’s particularly interesting because it can grow in almost any type of food
As Dr. Jekyll and his alter ego, Mr. Hyde, BoNTs also possess two seemingly disparate characteristics: is a widely
utilized therapeutic and cosmetic agent, and the cause of the lethal botulism
The objective of this work is to familiarize the ordinary people with C. botulinum and this two sides
INTRODUCTION
*Toxin E causes botulism almost exclusively in aquatic animals.
** It has been associated to sudden death but not with the 
neuroparalytic disease
Comparing the 16s rRNA sequences of the strains of 
C. botulinum…
THERAPEUTIC USE
BoNTs are now the most 
widely used therapeutic 
proteins  Due to their 
high efficacy, tolerance, 
longevity and 
satisfactory safety profile
Lu DW, Lippitz J. Complications of botulinum neurotoxin. Dis Mon. 2009
De Boulle KL. Botulinum neurotoxin type A in facial aesthetics. Expert Opin Pharmacother. 2007
Botox is the most common non-surgical cosmetic procedure 
worldwide
 Such use has increased by 4700% since 1997
 The effects last about three to four months
Botox (BoNT/A)
CONCLUSIONS
Although Clostridium botulinum is a microorganism that has been studied
much, there is still much research to be done!
All aspects involved in its mechanism of action, how can we prevent and /
or stop the intoxication as soon as possible to avoid the disease…
Even though botulism is not very frequent nowadays, we have to keep it in 
mind due to its high mortality and its possible use in a large-scale terrorist 
attack.
The future of BoNTs in therapeutic applications is bright, yet more research 
is needed to improve their medical uses. 
Study the mechanism of action in every application, approve more 
indications by the FDA and discover new ones
http://www.filmaffinity.com/es/film388608.html
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Cook properly 
to kill the toxin 
(85°C, 5 
minutes)
Avoid 
tasting food 
that might 
be spoiled
Never fed 
honey to 
infants 
younger than 
1 year old 
Adequate 
storage of 
food 
